ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Student in an Organized Health Care Education/Training Program

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 164

$458K Total Retail Price of All Prescriptions

Rank: 3 out of 164

429 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 677 596 1 2
LOVASTATIN 627 591 2 10
METFORMIN HCL 539 474 3 6
LEVOTHYROXINE SODIUM 413 368 4 11
AMLODIPINE BESYLATE 381 324 5 4
GABAPENTIN 269 241 6 19
FUROSEMIDE 251 251 7 14
ATENOLOL 242 238 8 7
HYDROCODONE-ACETAMINOPHEN 241 171 S3 9 1
SIMVASTATIN 240 221 10 3
HYDROCHLOROTHIAZIDE 224 196 11 5
ALENDRONATE SODIUM 217 217 12 16
METOPROLOL TARTRATE 194 167 13 12
OMEPRAZOLE 188 178 14 8
GLIPIZIDE 187 167 15 15
NORTRIPTYLINE HCL 136 130 16 34
BENAZEPRIL HCL 117 116 17 25
WARFARIN SODIUM 114 114 18 21
CITALOPRAM HBR 113 83 19 26
ATORVASTATIN CALCIUM 113 97 19 13
ZOLPIDEM TARTRATE 110 103 21 22
PRAVASTATIN SODIUM 108 96 22 20
METOPROLOL SUCCINATE 103 75 23 35
LOSARTAN POTASSIUM 102 98 24 9
DILTIAZEM 24HR ER 97 97 25 67
PANTOPRAZOLE SODIUM 97 82 25 37
TRAMADOL HCL 93 62 27 28
NIFEDIPINE ER 91 81 28 63
CARVEDILOL 88 88 29 32
DIGOXIN 84 84 30 104
TAMSULOSIN HCL 80 79 31 30
DICLOFENAC SODIUM 77 60 32 107
PAROXETINE HCL 74 74 33 78
ISOSORBIDE MONONITRATE ER 72 68 34 110
PROAIR HFA 72 65 34 18
CLOPIDOGREL 71 71 36 54
ALLOPURINOL 69 64 37 39
CLONIDINE HCL 68 62 38 69
PROPRANOLOL HCL 68 63 38 87
NIFEDIAC CC 65 63 40 88
LABETALOL HCL 65 52 40 123
SPIRIVA 64 52 42 42
MELOXICAM 62 56 43 36
NAMENDA 59 59 44 126
DONEPEZIL HCL 58 58 45 68
AMITRIPTYLINE HCL 58 25 R 45 129
KLOR-CON M20 56 56 47 136
INSULIN SYRINGE 56 51 47 27
LANTUS 55 40 49 137
HYDROCORTISONE 54 51 50 97
FLUTICASONE PROPIONATE 54 47 50 17
MECLIZINE HCL 53 53 52 142
PLAVIX 51 51 53 145
OXYBUTYNIN CHLORIDE 50 50 54 148
ACTONEL 50 50 54 148
TERAZOSIN HCL 50 50 54 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.